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ABSTRACT
DELTAMETHRIN INDUCES ENDOPLASMIC RETICULUM STRESS AND
INCREASES PROTEOTOXICITY IN CAENORHABDITIS ELEGANS
FEBRUARY 2019
YUEJIA XU, B.S., RUTGERS UNIVERSITY, NEW BRUNSWICK, NJ, USA
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST, MA, USA
Directed by: Professor Yeonhwa Park

Deltamethrin is a widely used type-II pyrethroid insecticide in agricultural,
industrial and domestic pest control. Previous studies have shown that deltamethrin can
induce ER stress response in vivo. However, it is still unclear whether deltamethrin can
disturb protein homeostasis. To investigate how deltamethrin affects ER protein
homeostasis, we used a C. elegans model of protein misfolding. In the current study,
deltamethrin induced ER stress response in C. elegans. Moreover, exposure to
deltamethrin increased the accumulation of unfolded and misfolded proteins in a C.
elegans model of polyglutamine aggregation in body wall muscles. Deltamethrin also
increased the toxicity of polyglutamine aggregates in C. elegans, as characterized by
decreased locomotion with deltamethrin treatment. These data indicate that exposure to
deltamethrin can induce ER stress response, increase the accumulation and proteotoxicity
of unfolded and misfolded proteins. As ER stress plays a pathological role in many
diseases, these findings provide evidence for the potential pathological role of
deltamethrin in ER stress-related diseases.
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CHAPTER 1
INTRODUCTION

Disturbances to the regular function of the endoplasmic reticulum (ER) can lead to the
accumulation of unfolded and misfolded proteins in the ER, a condition called ER stress
(1, 2). ER stress has been associated with the pathology of many conditions, including
aging, neurodegeneration, obesity, and diabetes (2, 3). Moreover, increasing evidence has
pointed out that environmental contaminants, like pyrethroid insecticides, can contribute
to diseases associated with ER stress (4, 5). Thus, identification of potential ER stressinducing environmental contaminants may help in the prevention and treatment of
diseases associated with ER stress.
Deltamethrin is a type II pyrethroid that is widely used as an insecticide in
agriculture, industrial, medical and home pest control (6, 7). Pyrethroids are considered
as low-toxicity replacements to organophosphorus and carbamate insecticides (6).
However, recent studies have indicated that a high level of exposure to deltamethrin can
result in convulsion, tremor, and ataxia in rodents (8-10). In addition, deltamethrin has
been found to induce ER stress response in vitro and in vivo (4, 11). Growing evidence
suggests that deltamethrin can induce ER stress and disturb protein homeostasis (4, 10,
11). Therefore, we investigate the role of deltamethrin in ER stress and protein
misfolding in vivo for the first time.
Caenorhabditis elegans, a free-living nematode, was used in this study as a model
organism to investigate the role of deltamethrin in ER stress, protein misfolding, and
proteotoxicity. C. elegans model has many advantages over rodent models, including
short lifespan, fully sequenced genome, and ease of maintenance (12). Additionally, this

1

nematode model has been established and used extensively for studies on ER stress and
protein misfolding (13). Therefore, C. elegans is an appropriate model to use in the
current study.
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CHAPTER 2
LITERATURE REVIEW

2.1 Introduction
Caenorhabditis elegans is a widely used animal model that has many advantages over
other in vivo models (12). The wildtype C. elegans has a short life cycle (about 2 days at
25°C), a relatively short lifespan (about 2-3 weeks), and a large brood size (more than
300 progeny) (12). In addition, experiments using C. elegans, which has a transparent
body, only require relatively simple laboratory conditions and do not need institutional
committee approval (12). For example, C. elegans is fed with non-pathogenic
Escherichia coli OP50 and raised on petri dishes or in liquid media (12). Thus, research
using C. elegans is much more time and cost-efficient than research using vertebrate
models. Moreover, C. elegans shares the basic biology of vertebrates; 83% of its
proteome is homologous to that of humans, and about two thirds of its genes are related
to human diseases (14). In addition, C. elegans has a completely sequenced genome and
more than 3,000 mutants are available, and RNA interference (RNAi), microinjection, as
well as genetic crosses, are amenable in this worm model (14). These reasons make this
animal model a powerful toolbox in many life science research areas (15).

2.2 Basic biology of C. elegans
C. elegans is a free-living nematode about 1-1.5 mm long in its adult stage (14). It has a
life cycle of about 2 days; this includes an embryonic stage, four larval stages (L1-L4),
and the adult stage (12). Its eggs have an impermeable shell that isolates them from the
outside environment (12). Hatched eggs turn into L1-stage worms, which proceed with
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adequate food into the L2-L4 stages in the developmental process. The cuticle of the
worms is reestablished after each larval stage (12). When the nematode encounters harsh
environments, including an absence of food and the presence of unfavorable chemicals, it
arrests development and enters a dormant state named a dauer larvae stage (16, 17).
Nematodes in the dauer stage will continue to grow into L4 stage worms with sufficient
food and favorable environmental conditions (16).
C. elegans has a high degree of cell differentiation and specialization (16). The
worm has five systems; the epidermis, and muscular, digestive, nervous, and reproductive
systems (16). The presence of well-defined tissues and organs makes the worm useful for
research in biological processes involved in multicellular organisms (18).
The epidermis of the worm is composed of epidermal cells that secrete the cuticle,
an exoskeleton that helps in the locomotion, protection, and growth of the worm (12).
The cuticle of C. elegans, which consists of collagens, proteins, glycoproteins, and lipids,
is reestablished five times during its development (12). Movement is controlled by
muscles that are attached to the epidermis (16). The relaxation and contraction of these
muscles are necessary for the sinusoidal movement of the animal (16). For example, one
of the unc (uncoordinated) genes, unc-54, encodes proteins that are needed for the typical
sinusoidal movement of the worms, and alterations to unc-54 can cause a paralytic
phenotype (16).
The digestive system of C. elegans is primarily composed of the pharynx,
intestine, rectum, and anus (16). When the worm eats, food passes through the mouth
opening first and then gets grinded at the pharynx (16). Next, the ground food reaches the
intestine, where it is further digested, and where nutrients are absorbed, utilized, or stored
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(12). After the food has been digested in the intestine, remaining waste passes the rectum
and anus and gets excreted through a rectal valve; the defecation cycle is about 50
seconds (12).
The nervous system of C. elegans contains 302 neurons for an adult
hermaphrodite (12). C. elegans has three classes of neurons; chemosensory,
mechanosensory, and thermosensory neurons (19). The worm model shares many
proteins with mammalian neurons involved in the formation, trafficking, and releasing of
synaptic vesicles (19). Because C. elegans uses many of the same neurotrasmitters as
vertebrates - including dopamine, serotonin, gamma-amino butyric acid, and
acetylcholine - it has been used as a model for many neurodegenerative diseases (16).
The reproductive tissue of the adult hermaphrodite C. elegans is comprised of the
somatic gonad that houses the germline and egg-laying apparatuses (12). Over 99% of
the worms are self-fertilizing hermaphrodites, which helps to preserve homozygous
clones (16).

2.3 ER Stress
Proteins are synthesized by the ribosomes attached to the rough ER. They are modified
and folded by chaperones and enzymes in the ER, and then transported out of the ERlumen (20). As the ER is a highly dynamic organelle, many parameters in the ER
microenvironment can affect the elements of protein folding, including chaperones,
foldases, calcium levels, the redox milieu, the phospholipid composition of the ER
membrane, etc. (20). Once protein folding is disturbed or inadequate, unfolded and
misfolded proteins can accumulate in the ER lumen and the cytoplasm, a condition
named ER stress (1, 2). The ER has a ‘quality control’ system to degrade unfolded and
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misfolded proteins: the ER-associated degradation (ERAD) pathway delivers damaged
protein to the proteasome, and the autophagy pathway transports unfolded and misfolded
proteins to the lysosome (21). However, overaccumulation of unfolded and misfolded
proteins leads to activation of the unfolded protein response (UPRER), which has both
protective and apoptotic components (22). It has been reported that the UPRER has a
pathological role in many conditions, including aging, neurodegenerative diseases,
obesity, and type 2 diabetes (2). Thus, understanding the role of UPRER may provide
important insights into the pathology and new treatment of these and other diseases.

2.4 Unfolded protein response in ER (UPRER)
The UPRER is a signaling pathway that is conserved from yeasts to mammals, which
allows researchers to study this pathway in a variety of models, including C. elegans
(23). The UPRER stress response system can monitor the accumulation of unfolded and
misfolded proteins and correct protein folding and processing (20). The UPRER system
tries to maintain normal cell function by reducing protein-folding workload,
strengthening protein-folding capacity, as well as removing and degrading unfolded and
misfolded proteins (23). However, when ER stress cannot properly handle unfolded and
misfolded proteins, the apoptotic pathway can be triggered by the UPRER via UPRER
signaling pathways (20).

2.5 The UPRER Signaling Pathways
The UPRER system includes three branches, each represents by one of three
transmembrane proteins: the inositol-requiring kinase-1 (IRE-1), protein kinase RNA-like
endoplasmic reticulum kinase (PERK), and activating transcription factor-6 (ATF-6)
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(23). All these branches have a luminal domain that can sense the amount of unfolded
and misfolded proteins and initiate responses to manage ER stress (21).

2.5.1 IRE-1 Pathway
The IRE-1 branch of the UPRER is conserved from yeasts to humans (5). Although the
exact mechanism of IRE-1 activation is not completely understood, one study suggests
that unfolded and misfolded proteins, as well as binding immunoglobulin protein (BiP),
participate in modulation of IRE-1 (24). Without unfolded or misfolded proteins, BiP
binds to IRE-1 to inhibit its activity (25). In the presence of unfolded and misfolded
proteins, BiP binds to them and activates IRE-1 (25). Activation of IRE-1 results in the
dimerization and autophosphorylation of the protein (26). The activated IRE-1 acts as an
endoribonuclease that cleaves a 26-base fragment from X-box binding protein-1 (XBP-1)
mRNA, and the spliced mRNA is translated into spliced X-box binding protein-1 (spliced
XBP-1) (26). In mammals, spliced XBP-1s regulate components in protein degradation,
protein folding, and ER membrane biogenesis, and this regulation can alleviate ER stress
as well as increase ER capacity (26). In C. elegans, spliced XBP-1s can upregulate heat
shock protein 4 (HSP-4, the homolog of mammalian BiP), as well as ER-associated
Degradation (ERAD) components and other chaperones (27-31).

2.5.2 PERK Pathway
PERK is an ER-resident transmembrane protein (32). PERK is activated by dissociation
of BiP from its luminal domain (25). The activated PERK can phosphorylate eukaryotic
translational initiation factor 2α (eIF2α) and downregulate global protein synthesis to
alleviate ER workload (32). Moreover, the activation of eIF2α can also increase the
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translation of protective proteins, including activating transcription factor 4 (ATF4) (33).
In mammals, ATF4 controls a range of target genes, including the pro-apoptotic
transcription factor, C/EBP homologous protein (CHOP) (34-36). The downstream
targets of ATF4 in C. elegans are, however, still not known.

2.5.3 ATF6 Pathway
ATF-6 is a transmembrane transcription factor that is activated upon accumulation of
unfolded and misfolded proteins (34). Once activated, ATF-6 translocates to the Golgi
apparatus, where it is cleaved by site-1 protease (S1P) and site-2 protease (S2P) to
generate the cleaved form of ATF-6 (5). Once cleaved, ATF-6 upregulates a wide range
of UPRER target genes, including chaperones, protein foldases, and components in the
protein degradation ERAD pathway in mammals (5). However, in C. elegans, ATF-6
regulates fewer target genes than in mammals, and the specific role of ATF-6 branch in
C. elegans is still to be determined (37).

2.6 Conditions related to ER Stress and the UPRER
2.6.1 Aging and Reduced UPRER
The ability of UPRER to respond to ER stress declines with age. This may allow for an
accumulation of unfolded and misfolded proteins and contribute to age-related diseases
(35). In addition, the UPRER response to protein chaperones and foldases also decreases
with aging (38). Many of these chaperones suffer oxidative damage during aging, which
can further imperil the function of the UPRER system (39). The decline in the protective
role of the UPRER during aging is accompanied by an increase of pro-apoptotic markers
in the UPRER (38). Expression of pro-apoptotic markers, including C/EBP homologous
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protein (CHOP) and caspase-12, are upregulated in the aged, but not young rats, when
treated with lactacystin, a proteasome inhibitor that disrupts protein homeostasis (40).
Thus, overall, aging reduces the protective functions of the UPRER and strengthens its
pro-apoptotic signaling, which further leads to age-related accumulation of unfolded and
misfolded protein and cell dysfunction.
The homolog of insulin/insulin-like growth factor receptor (IIS), DAF-2, is well
known to be associated with lifespan in C. elegans (41). The DAF-2 mutant has an
extended lifespan that depends on the activation of the forkhead box transcription factor
(FOXO). In addition, UPRER components ire-1 and xbp-1 are involved in lifespan
extension, which occurs as xbp-1 upregulates daf-16 in the DAF-2 mutant (42).
In addition to IIS, protein skinhead-1 (skn-1), the mammalian homolog of nuclear
respiratory factor 2 (Nrf2), has been associated with longevity in C. elegans (43). A
recent report indicates that Vitamin D can extend lifespan through activation of skn-1 in
C. elegans, and the activation of skn-1 requires UPRER components ire-1 and xbp-1 (44).
Consistently, others have reported that skn-1 contributes to longevity by activating the
IRE-1 and PERK branches of the UPRER (33).
Improving ER protein homeostasis also contributes to longevity in C. elegans
(35). As UPRER regulates many components that can improve ER protein homeostasis
(41), upregulation of UPRER can improve age-related diseases (45). In fact, the activation
of the hexosamine pathway, which has been linked to UPRER upregulation, can improve
longevity and reduce protein aggregation by enhancing ER-associated protein
degradation, proteasome function, and autophagy in C. elegans (45, 46).
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2.6.2 Neurodegenerative disease
A common pathological marker for many neurodegenerative disorders is the
accumulation of unfolded and misfolded proteins in neurons (47). Thus, studying
stressors and potential therapies that target unfolded and misfolded proteins may provide
a better understanding of these disorders and play a crucial role in the development of
preventive and treatment strategies for these neurodegenerative disorders (47).
2.6.2.1 Alzheimer’s Disease
Alzheimer’s is a neurodegenerative disease exhibiting the presence of extracellular senile
plaques and intracellular neurofibrillary tangles (17). The major component of senile
plaques is β-amyloid (Aβ), while the neurofibrillary tangles are formed by aggregation of
tau proteins (17). Many studies have reported that ER stress and the UPRER system are
involved in the development of Alzheimer’s disease (48, 49). Recent studies have shown
that Aβ can accumulate at the ER lumen and increase free and bound Ca2+ in neurons
(50). This causes ER stress and activation of the UPRER (50), which leads to impaired
synaptic function and eventually induces apoptosis of neurons (49). In addition, a protein
associated with Alzheimer’s disease, mutated presenilin-1, can increase Ca2+ release in
the ER and inhibit IRE-1 activity, which worsen ER homeostasis and reduce UPRER
signaling (51).
In humans, Aβ is produced when amyloid precursor protein (APP) is cleaved by
β- and γ-secretase (17). However, the C. elegans homolog of APP, apl-1, does not
contain the genetic information for β-amyloid (17). Thus, researchers have created C.
elegans models of Alzheimer’s disease by introducing human Aβ1-42 to generate
transgenic strains (52). They have applied these models to screen bioactive compounds
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and discover contributors to the disease (52). Using this model, resveratrol is reported to
reduce the toxicity of Aβ aggregation through upregulation of autophagy and proteasomal
degradation (52). Ablation of the IRE-1 branch of the UPRER may reduce the toxicity of
β-amyloid, although the role of IRE-1 in Alzheimer’s disease has been controversial (53,
54).

2.6.2.2 Parkinson’s Disease
Parkinson’s disease is a neurodegenerative disorder marked clinically by tremors,
bradykinesia, and impaired balance (14). These have been associated with two main
pathological hallmarks: the formation of proteinaceous inclusions (Lewy Bodies) and the
loss of dopaminergic neurons from the substantia nigra (14). Recent studies have
identified a pathological role for ER stress in Parkinson’s disease (55). Aggregation of αsynuclein in the ER can impact ER homeostasis, including depletion of ER chaperones
and inhibition of ER-to-Golgi trafficking (56-58). Although it is generally agreed that ER
stress is involved in the neuropathology of Parkinson’s Disease, the exact mechanism for
how induction of ER stress causes the loss of dopaminergic neurons in Parkinson’s
disease is not yet well understood (58).
In humans, α-synuclein aggregates are products of the α-syn gene (14). Because
C. elegans does not possess this gene (14), C. elegans’ models of α-synuclein are
established with human α-synuclein expression in neurons or muscle promoters (19). In
addition, neurotoxins like 6-hydroxydopamine can be used to degenerate dopaminergic
neurons in C. elegans, which also induces ER stress (59). Consistently, mutation of
leucine-rich repeat kinase 2 (LRRK2), a gene commonly associated with Parkinson’s
disease, has been shown to inhibit UPRER responses, leading to increased ER stress in C.
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elegans (59). Moreover, a type of bacterial metabolite, phenazine derivatives, has been
shown to exacerbate ER stress in the worm model of Parkinson’s disease (13).

2.6.2.3 Huntington’s Disease
Huntington’s disease is an inherited neurodegenerative disease that results in cognitive,
motor, and psychiatric changes (60). This disease results from expansion of CAG repeats
in the Huntingtin gene that adds a long polyglutamine repeat to the Huntingtin protein
(60). Recent studies have linked ER stress to the development of Huntington’s Disease in
several ways: [1] polyglutamine fragments can entrap ERAD proteins (Npl4, Ufd1, and
p97) and induce ER stress (61), [2] overexpression of these ERAD proteins can reduce
the toxicity caused by polyglutamine (61), and [3] polyglutamine indirectly increases
accumulation of unfolded and misfolded proteins by disruption of vesicular trafficking
and by causing defects in lysosome-mediated protein degradation (62).
In C. elegans, the human huntingtin-polyglutamine protein is incorporated in
muscle or neurons to generate disease models for relatively easy detection of disease
development (18, 63). Using these models, UPRER components and changes in the
disease progression can be investigated. For example, manganese treatment can induce
ER stress and increase polyglutamine aggregates as an indicator of Huntington’s disease
(64). This provides further evidence that ER stress is associated with the development of
Huntington’s disease (64).

2.6.2.4 Obesity and Type 2 Diabetes
Obesity is also known to be associated with increased ER stress and activated UPRER in
many tissues, such as hypothalamus, liver, muscle, and adipose tissue (65). Treatment of
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chemical chaperones, which improve protein folding and synthesis, can improve ER
function and reduce ER stress markers in the liver and adipose tissue of obese mice (66).
This indicates that obesity-associated ER stress may result from a high protein synthesis
load (66). In addition, increased free fatty acid load, as well as changes in the
composition of the ER membrane, can also activate the UPRER, which suggests that the
UPRER responds to lipid imbalances (67-70).
The activated UPRER plays a significant role in the development of obesity-related
disorders, particularly type 2 diabetes (65). Increased ER stress in obesity can lead to the
induction of c-Jun N-terminal kinases (JNK), and thus reduce the activity of insulin
receptor substrate-1 (IRS1) to down-regulate insulin signaling (66). The UPRER also
interacts with hepatic gluconeogenesis by ATF-6, one of the three branches of the
UPRER, to inhibit the activity of CREB-regulated transcription coactivator 2 (CRTC2),
which results in down-regulation of gluconeogenesis in the liver (71). With increased
insulin demand due to insulin resistance, the pancreatic β-cells can exceed their protein
folding capacity and generate ER stress (5). Eventually, prolonged ER stress in the
pancreas can trigger the UPR-mediated apoptosis in β-cells, exacerbate hyperglycemia,
and eventually increase insulin deficiency (22).
C. elegans is an established model for research in obesity and type 2 diabetes. The
key pathways on energy metabolism, such as the lipid metabolism and insulin/insulin-like
growth factor signaling (IIS), are conserved between mammals and C. elegans (72). For
example, researchers have found that a change of phospholipid composition in the ER
membrane in C. elegans can activate UPRER without disturbing ER proteostasis (68).
This indicates that in C. elegans lipid imbalance may directly activate the UPRER (68),
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which is consistent with observations in mammals (73). Thus, the worm model has
tremendous potential for valuable research in obesity and diabetes, particularly research
in ER stress- and UPR- mediated mechanisms.

2.7 Conclusion
The introduction of the C. elegans model of human diseases has provided a versatile and
powerful platform for studying the pathology and potential treatments of these diseases.
As one of the complex pathways in cells, UPRER is involved in the pathology of many
diseases. Using the worm model to study the UPRER already has been proven to be
fruitful, and continued discoveries using this worm model will provide important insights
in research related to the UPR and to human diseases in the future.
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CHAPTER 3
MATERIALS AND METHODS

3.1 Materials
All the C. elegans strains and Escherichia coli OP50 used in the current study
were obtained from Caenorhabditis Genetics Center (CGC), University of Minnesota.
Strains used include SJ4005 [zcIs4 (phsp-4::GFP)]; AM141[rmIs133 (unc54p::Q40::YFP)]. All the chemicals were purchased from Thermo Fisher Scientific
(Pittsburgh, PA, USA) unless otherwise indicated. Household Clorox bleach (The Clorox
Company, Oakland, CA, USA) was used for synchronizing the worms.
Fluorodeoxyuridine (FUdR) and carbenicilin were purchased from Sigma-Aldrich Co.
(St. Louis, MO, USA).

3.2 C. elegans Culture
C. elegans were cultured using standard methods as previously described (74).
Nematode growth medium (NGM), M9-buffer solution, and S-complete solution were
prepared as the previous protocols (74). Briefly, after a synchronous worm population
was acquired, synchronized L1 worms were cultured in 12-wells plates at 25°C with
treatments (25 µM deltamethrin or 0.1% DMSO as control).

3.3 Fluorescence Microscopy
Worms were immobilized in 2 mM levamisole and mounted on a slide with 3%
agarose using a cover slip before imaging. After preparation of the slides, fluorescent
images were taken using a Nikon Eclipse Ti-U Inverted Microscope (Micro Video
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Instruments, Avon, MA). The average GFP intensity of SJ4005 worms was measured for
ER stress response, and the average number and size of polyglutamine YFP inclusions
were scored for AM141 worms. For each treatment, about 30 worms were used. Analysis
of the images was performed using the ImageJ software developed by the National
Institute of Health (NIH).

3.4 Growth Rate Assay
After 48 hours of treatment, worms were transferred from liquid media to NGM
plates, and the worms at each developmental stage were counted for growth rate analysis.

3.5 Locomotion Assay
Locomotion activity of the worms was measured using the Wormlab tracking
system (MBF Bioscience, Williston, VT, USA) as previously described (75, 76). Lowpeptone nematode growth media (NGM) plates were prepared and used for tracking as
previously reported (75). Worms from each treatment groups were transferred from liquid
media to NGM plates and stabilized for about 15 minutes. After stabilization, a 1-minute
video was captured at 7.99 frames per second. Videos were analyzed using the Wormlab
software, and the Wormlab software generated data for worm size and locomotive
behavior.

3.6 Statistical Analysis
Data values are given as means ±S.E. and analyzed using statistical software
GraphPad Prism v.7.0 (GraphPad Software, La Jolla, CA, USA). Differences among
groups were analyzed using one-way or two-way analysis of variance (ANOVA) and
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Tukey’s multiple-range test. The significance of differences was defined at the P < 0.05
level.
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CHAPTER 4
RESULTS

4.1 Deltamethrin induces ER stress response in C. elegans
The induction of ER stress response in worms can be measured by using the SJ4005
strain with an hsp-4p::GFP reporter. Hsp-4 is the homolog of mammalian ER chaperone
BiP, and BiP is used as a general marker of ER stress response (5). During ER stress, hsp4 is upregulated and the GFP intensity in SJ4005 worms is higher than without ER stress
(68). The expression of the hsp-4 GFP reporter was measured to investigate whether
deltamethrin can induce ER stress response in C. elegans. In this experimental, a 4-hour
treatment of 3 mM dithiothreitol (DTT), an ER stress inducer, was used as positive
control. As shown in Figure 4.1, 25 µM deltamethrin increased the ER stress response
significantly by 44% compared to control. Since the induction of ER stress is associated
with the accumulation of unfolded and misfolded proteins, the effect of deltamethrin on
protein misfolding was examined using a C. elegans polyglutamine model (64).
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Figure 4.1 Effects of deltamethrin on ER stress response. (A) Representative images of
SJ4005 worms on day 3 with control, deltamethrin and dithiothreitol (DTT) treatments.
(B) Deltamethrin induced ER stress response in C. elegans. Treatment of deltamethrin
started from L1 stage for three days. The data are described as means ±S.E. (control
n=29, deltamethrin n=36, DTT n=69). Means with different letters are significantly
different (P<0.05).
4.2 Effect of deltamethrin on locomotive activity, growth rate and worm size
Exposure to deltamethrin has been linked to the reduction of locomotive activities in C.
elegans (77) and improper development in zebrafish and Daphnia (4, 78). However,
treatment of deltamethrin at 25 µM had no significant effects on the size (Figure
4.2A&B), and locomotive activities (Figure 4.2C&D) or growth rate of C. elegans strain
SJ4005 (Figure 4.2E).
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Figure 4.2 Effects of deltamethrin on the size, growth rate, and locomotive activity of
SJ4005 worm. (A) Average body length of worms on day 4 of treatment. (B) Average
body width of worms on day 4 of treatment. (C) Average moving speed on day 4 of
treatment. (D) Mean amplitude of sinusoidal movement on day 4 of treatment. (E)
Proportion of worms of each growth stage after 2 days of treatment. All worms were
treated with deltamethrin from L1 stage. And the data were presented as mean means ±
S.E. (n=184-191 for size and locomotion assay; n=3 plates and about 100 worms per
plate for growth rate assay). Means with different letters are significantly different
(P<0.05).
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4.3 Deltamethrin increased polyglutamine aggregation in C. elegans
The effect of deltamethrin on the aggregation of polyglutamine is tested using the C.
elegans transgenic strain AM141 expressing Q40::YFP in its body wall muscle cells (64).
Expression of polyglutamine stretch leads to the formation of aggregation that can be
visualized by fluorescent microscopy (79). Our results showed that treatment with 25 µM
of deltamethrin had no significant effect on the average number of polyglutamine
aggregates (Figure 4.3A), but significant changes in the average size of polyglutamine
aggregates occurred (Figure 4.3B). According to previous studies, increased
polyglutamine aggregation may result in polyglutamine-mediated motility defects (79).
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Figure 4.3 Effects of deltamethrin on the number and size of polyglutamine aggregation
in C. elegans. (A) The number of polyglutamine aggregation was counted from YFP
images using ImageJ. (B) The average size of polyglutamine aggregation was counted
from YFP images using ImageJ. (C) Representative images of AM141 worms treated
with 0.1% DMSO in control group. (D) Representative images of AM141 worms treated
with 25 µM deltamethrin. Treatment of deltamethrin starts from L1 stage and lasts for six
days. The data are described as means ±S.E. (control n=33, deltamethrin n=37). Means
with different letters are significantly different (P<0.05).
4.4 Deltamethrin increased the proteotoxicity of polyglutamine in C. elegans
Prior studies have shown that polyglutamine aggregates can induce proteotoxicity in
muscle cells of C. elegans by disrupting the actin and myosin myofibrillar networks (79).
As a result of the polyglutamine-mediated proteotoxicity, the worms show a reduction in
locomiton (79). In the current study, the locomotive activity was measured using
WormLab system on day 4 with or without deltamethrin to investigate whether
deltamethrin would exacerbate the proteotoxicity of polyglutamine. Average moving
speed means the average distance the worm moves during a specified time period, and
amplitude refers to the distance of vertical movement over the sinusoidal track of C.
elegans (75). As for body size, treatment of 25 μM deltamethrin resulted in a significant
reduction in body length by 7% (Figure 4.4A), but result in no significant changes in
body width (Figure 4.4B). In terms of locomotive activities, deltamethrin treated worms
had a significant reduction in average moving speed (~31%) (Figure 4.4C) and a
significant reduction in mean amplitude (~11%) (Figure 4.4D). Furthermore, the growth
rate (Figure 4.4E) of worms was not significantly different between control and
deltamethrin-treated groups. Overall, these results indicate that deltamethrin treatment
exacerbates the proteotoxicity of polyglutamine aggregation.
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Figure 4.4 Effects of deltamethrin on the size, growth rate, and locomotive activity of
AM141 worm. (A) Average body length of worms on day 4 of treatment. (B) Average
body width of worms on day 4 of treatment. (C) Average moving speed on day 4 of
treatment. (D) Mean amplitude of sinusoidal movement on day 4 of treatment. (E)
Proportion of worms of each growth stage after 2 days of treatment. All worms were
treated with deltamethrin from L1 stage. The data were presented as mean means ±S.E.
(n=187-194 for size and locomotion assay; n=3 plates and about 100 worms per plate for
growth rate assay). Means with different letters are significantly different (P<0.05).
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CHAPTER 5
DISCUSSION
Previously, others have reported that deltamethrin induces ER stress response/ unfolded
protein response (UPRER) in nerve cells and mice (4, 11). In the current study,
deltamethrin treatment induced ER stress response in C. elegans, and is the first report
that deltamethrin increased protein misfolding and exacerbated proteotoxicity in vivo
using C. elegans.
ER is the organelle that synthesizes, folds and processs proteins and ER stress is
defined as a condition where unfolded and misfolded proteins accumulate in the ER
lumen and activate the ER stress response/UPRER (5, 68). Disruption of the protein
folding and processing in ER can lead to accumulation of unfolded and misfolded
proteins in the ER and trigger a specific stress response named the UPRER (5).
Accumulation of unfolded and misfolded proteins plays a pathological role in many
conditions, including aging, obesity, diabetes, and neurodegeneration diseases (2, 13, 65).
For example, under ER stress, overaccumulated unfolded and misfolded proteins can
form inclusions in neuron cells, and many of these inclusions (e.g. α-synuclein and βamyloid) have been proven to be neurotoxic (2, 58). Previous reports have indicated that
deltamethrin can induce ER stress response/UPRER (4, 11). However, induction of ER
stress response/UPRER alone may not directly indicate accumulation of unfolded and
misfolded proteins, because UPRER can be activated by other conditions without
accumulation of unfolded and misfolded proteins, such as change of ER membrane
phospholipid composition, oxidative stress, and metabolic stress (5, 33, 68). In the
current study, we confirmed that deltamethrin caused protein misfolding and
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proteotoxicity along with induction of ER stress response/UPRER in C. elegans by using a
protein misfolding model based on polyglutamine aggregation.
In the current study, deltamethrin increased polyglutamine aggregation and
resulted in proteotoxicity, as determined by reduced average moving speed and amplitude
(80). Increased polyglutamine aggregation seen in the presence of deltamethrin may have
occurred due to a slowing or disruption of the removal of unfolded and misfolded
proteins in the lysosome-mediated protein degradation process (62, 79). A previous study
implied that deltamethrin activated the UPRER and impaired the hippocampal function
possibly by UPRER-mediated apoptosis (4). Others suggested that deltamethrin activated
general ER stress response and induced apoptosis through activation of the PERK branch
of the UPRER in SK-N-AS neuroblastoma cells (11). Another pyrethroid insecticide,
cypermethrin, impaired proteostasis by alterations to protein synthesis, maturation, and
degradation genes in the brain of mice (81). Our results are consistent with these reports
that deltamethrin may induce ER stress and protein misfolding. The alteration of calcium
homeostasis and oxidative stress associated with deltamethrin, however, may also
contribute to its effects on ER stress (77, 82). Thus, it is still not clear how deltamethrin
increased polyglutamine aggregation and proteotoxicity.
Our results also showed that the worm length of AM141 worms was slightly, but
significantly, reduced (7%) by deltamethrin and may indicate that deltamethrin had
affected the development of C. elegans. Interestingly, deltamethrin did not influence the
growth rate of AM141 worms, nor did it reduce the worm length in SJ4005 worms. These
results are consistent with a previous report that deltamethrin has little to minimal impact
on the growth rate of C. elegans (6). It has been previous shown that extreme ER stress
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can lead to developmental arrest and larvae lethality in C. elegans, whereas moderate
level of ER stress has no significant effect on the development of worms (68, 83). Based
on the above evidence, it appears that deltamethrin treatment at 25 μM had a moderate
effect on ER stress but had limited influence on the development of C. elegans.
Pyrethroids have been reported to affect locomotive activity in many animal
models as it targets neurons (84). Nonetheless, our results implied that deltamethrin of 25
μM had no significant effect on body size, locomotion, or growth rate of SJ4005 worms.
However, deltamethrin showed a dose-dependent effect on the locomotion of wild-type
C. elegans (75). It is possible that the difference in C. elegans strain may be the reason
why no significant changes on locomotive activity by deltamethrin in the current study
with SJ4005 worms. In fact, it has been reported that the insertion of the GFP reporter
into the hsp-4 gene intragenetically affected the locomotive behavior of SJ4005 worms,
as the average speed of SJ4005 worms is slower than that of the N2 worm used in the
previous study (6, 85).
Overall, the current results suggest that deltamethrin induces ER stress response
in C. elegans and increases accumulation as well as the proteotoxicity of polyglutamine
aggregates. Further studies are necessary, however, to determine how deltamethrin
induces ER stress response and increases protein misfolding by examining potential
mechanisms, including calcium homeostasis and oxidative stress.
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CHAPTER 6
FUTURE DIRECTIONS
Currently, there are limited reports on the role of deltamethrin in ER stress and ER stressrelated diseases. In the present study, we discovered that deltamethrin can induce ER
stress, increase accumulation of unfolded and misfolded proteins, and increase the
proteotoxicity of polyglutamine aggregation in C. elegans. However, the exact
mechanism how deltamethrin induces ER stress and disturbs protein homeostasis is not
known. Since deltamethrin alters the activity of both voltage-gated sodium and calcium
channel, deltamethrin may disturb ER protein homeostasis and triggers UPRER through
increasing the calcium concentration (5, 77). In order to test this hypothesis in C. elegans,
the expression level of ER Calcium transporter SERCA (Sarco/Endoplasmic Reticulum
Calcium ATPase) may be evaluated to determine if deltamethrin disturbs the calcium
homeostasis in the ER (86). The expression of SERCA is expected to increase if
deltamethrin increased ER Ca2+ level (86). Alternatively, deltamethrin may also impact
protein folding and processing through reduction of proteasomal and ribosomal activities,
which can be examined by analyzing proteasomal activities using a fluorogenic peptide
substrate assay and quantifying ribosomes in C. elegans (52). Moreover, the effect of
deltamethrin has not been tested on all three branches of UPRER. The IRE-1 and the
PERK branches are expected to be activated with deltamethrin treatment, as the
activation of both branches was reported in the neurons (11).

27

BIBLIOGRAPHY
1. Pagliassotti MJ, Kim PY, Estrada AL, Stewart CM, Gentile CL. 2016. Endoplasmic
reticulum stress in obesity and obesity-related disorders: An expanded view. Metabolism
65: 1238-1246.
2. Lin JH, Walter P, Yen TSB. 2008. Endoplasmic reticulum stress in disease
pathogenesis. Annu.Rev.Pathol.Mech.Dis. 3: 399-425.
3. Labbadia J, Morimoto RI. 2015. The biology of proteostasis in aging and disease.
Annu.Rev.Biochem. 84: 435-464.
4. Richardson J, Hossain MM, Richardson JR, DiCicco-Bloom E. 2015. Hippocampal ER
stress and learning deficits following repeated pyrethroid exposure. Toxicol. Sci. 143:
220-228.
5. Wang S, Kaufman RJ. 2012. The impact of the unfolded protein response on human
disease. J.Cell Biol. 197: 857-867.
6. Shen P, Hsieh TH, Yue Y, Sun Q, Clark JM, Park Y. 2017. Deltamethrin increases the
fat accumulation in 3T3-L1 adipocytes and Caenorhabditis elegans. Food Chem.Toxicol.
101: 149-156.
7. Yoon KS, Kwon DH, Strycharz JP, Hollingsworth CS, Lee SH, Clark JM. 2008.
Biochemical and molecular analysis of deltamethrin resistance in the common bed bug
(Hemiptera: Cimicidae). J.Med.Entomol. 45: 1092-1101.
8. Godin SJ, DeVito MJ, Hughes MF, Ross DG, Scollon EJ, Starr JM, Setzer RW,
Conolly RB, Tornero-Velez R. 2010. Physiologically based pharmacokinetic modeling of
deltamethrin: Development of a rat and human diffusion-limited model. Toxicol.Sci. 115:
330-343.
9. Woodward KN. 2013. Veterinary products containing pesticide active ingredients.
Cambridge : Royal Society of Chemistry.
10. Soderlund DM, Clark JM, Sheets LP, Mullin LS, Piccirillo VJ, Sargent D, Stevens JT,
Weiner ML. 2002. Mechanisms of pyrethroid neurotoxicity: Implications for cumulative
risk assessment. Toxicology 171: 3-59.
11. Hossain MM, Richardson JR. 2011. Mechanism of pyrethroid pesticide-induced
apoptosis: Role of calpain and the ER stress pathway. Toxicol.Sci. 122: 512-525.
12. Shen P, Yue Y, Park Y. 2018. A living model for obesity and aging research:
Caenorhabditis elegans. Crit.Rev.Food Sci.Nutr. 58: 741-754.

28

13. Ray A, Rentas C, Caldwell GA, Caldwell KA. 2015. Phenazine derivatives cause
proteotoxicity and stress in C. elegans. Neurosci.Lett. 584: 23-27.
14. Dexter PM, Caldwell KA, Caldwell GA. 2012. A predictable worm: Application of
Caenorhabditis elegans for mechanistic investigation of movement disorders.
Neurotherapeutics 9: 393-404.
15. Nussbaum-Krammer C, Morimoto RI. 2014. Caenorhabditis elegans as a model
system for studying non-cell-autonomous mechanisms in protein-misfolding diseases.
Dis. Models Mech. 7: 31-39.
16. Corsi AK, Wightman B, Chalfie M. 2015. A transparent window into biology: A
primer on Caenorhabditis elegans. Genetics 200: 387-407.
17. Shen P, Yue Y, Zheng J, Park Y. 2018. Caenorhabditis elegans: A convenient in vivo
model for assessing the impact of food bioactive compounds on obesity, aging, and
Alzheimer's disease. Annu.Rev.Food Sci.Technol. 9: 1-22.
18. Brignull HR, Morley JF, Garcia SM, Morimoto RI. 2006. Modeling polyglutamine
pathogenesis in C. elegans. In Methods in Enzymology. Wetzel R, Kheterpal I, eds.
Academic Press, New York, NY, United States. Vol 412, p 256-282.
19. Teschendorf D, Link CD. 2009. What have worm models told us about the
mechanisms of neuronal dysfunction in human neurodegenerative diseases?
Mol.Neurodegener 4: 38.
20. Schoenthal AH. 2012. Endoplasmic reticulum stress: Its role in disease and novel
prospects for therapy. Scientifica 2012: 857516.
21. Labbadia J, Morimoto RI. 2015. The biology of proteostasis in aging and disease.
Annu.Rev.Biochem. 84: 435-464.
22. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ. 2008. Chop deletion reduces
oxidative stress, improves beta cell function, and promotes cell survival in multiple
mouse models of diabetes. J.Clin.Invest. 118: 3378-3389.
23. Oakes SA, Papa FR. 2015. The role of endoplasmic reticulum stress in human
pathology. Annu.Rev.Pathol.Mech.Dis. 10: 173-194.
24. Pincus D, Chevalier MW, Aragon T, van Anken E, Vidal SE, El-Samad H, Walter P.
2010. BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the
unfolded protein response. PLoS Biol. 8: e1000415.
25. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic
interaction of BiP and ER stress transducers in the unfolded-protein response. Nat.Cell
Biol. 2: 326-332.

29

26. Rubio C, Pincus D, Korennykh A, Schuck S, El-Samad H, Walter P. 2011.
Homeostatic adaptation to endoplasmic reticulum stress depends on Ire1 kinase activity.
J.Cell Biol. 193: 171-184.
27. Taylor RC, Dillin A. 2013. XBP-1 is a cell-nonautonomous regulator of stress
resistance and longevity. Cell 153: 1435-1447.
28. Lee D, Singaravelu G, Park BJ, Ahnn J. 2007. Differential requirement of unfolded
protein response pathway for calreticulin expression in Caenorhabditis elegans.
J.Mol.Biol. 372: 331-340.
29. Eletto D, Eletto D, Dersh D, Gidalevitz T, Argon Y. 2014. Protein disulfide
isomerase A6 controls the decay of IRE1alpha signaling via disulfide-dependent
association. Mol.Cell 53: 562-576.
30. Caruso ME, Jenna S, Bouchecareilh M, Baillie DL, Boismenu D, Halawani D,
Latterich M, Chevet E. 2008. GTPase-mediated regulation of the unfolded protein
response in Caenorhabditis elegans is dependent on the AAA+ ATPase CDC-48.
Mol.Cell.Biol. 28: 4261-4274.
31. Safra M, Henis-Korenblit S. 2014. A new tool in C. elegans reveals changes in
secretory protein metabolism in ire-1-deficient animals. Worm 3: e27733.
32. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. 2000. Perk is essential for
translational regulation and cell survival during the unfolded protein response. Mol.Cell 5:
897-904.
33. Glover-Cutter K, Lin S, Blackwell TK. 2013. Integration of the unfolded protein and
oxidative stress responses through SKN-1/nrf. PLoS Genet. 9: e1003701.
34. Walter P, Ron D. 2011. The unfolded protein response: From stress pathway to
homeostatic regulation. Science 334: 1081-1086.
35. Taylor RC. 2016. Aging and the UPR(ER). Brain Res. 1648: 588-593.
36. Martinez G, Duran-Aniotz C, Cabral-Miranda F, Vivar JP, Hetz C. 2017.
Endoplasmic reticulum proteostasis impairment in aging. Aging Cell 16: 615-623.
37. Shen X, Ellis RE, Sakaki K, Kaufman RJ. 2005. Genetic interactions due to
constitutive and inducible gene regulation mediated by the unfolded protein response in C.
elegans. PLoS Genet. 1: e37.
38. Naidoo N. 2009. Review: ER and aging—Protein folding and the ER stress response.
Ageing Res.Rev. 8: 150-159.

30

39. Nuss JE, Choksi KB, DeFord JH, Papaconstantinou J. 2008. Decreased enzyme
activities of chaperones PDI and BiP in aged mouse livers.
Biochem.Biophys.Res.Commun. 365: 355-361.
40. Paz GM, Vela J, Castano A, Ramos B, del Rio JC, Vitorica J, Ruano D. 2006.
Cellular environment facilitates protein accumulation in aged rat hippocampus.
Neurobiol.Aging 27: 973-982.
41. Taylor RC, Dillin A. 2011. Aging as an event of proteostasis collapse. Cold Spring
Harb Perspect.Biol. 3: a004440.
42. Henis-Korenblit S, Zhang P, Hansen M, McCormick M, Lee S, Cary M, Kenyon C.
2010. Insulin/IGF-1 signaling mutants reprogram ER stress response regulators to
promote longevity. Proc.Natl.Acad.Sci.U.S.A. 107: 9730-9735.
43. Ewald C, Steinbaugh M, Blackwell TK, Steinbaugh MJ, Hourihan JM, Ewald CY,
Isik M. 2015. SKN-1/nrf, stress responses, and aging in Caenorhabditis elegans. 88: 290301.
44. Mark KA, Dumas KJ, Bhaumik D, Schilling B, Davis S, Oron TR, Sorensen DJ,
Lucanic M, Brem RB, Melov S, Ramanathan A, Gibson BW, Lithgow GJ. 2016. Vitamin
D promotes protein homeostasis and longevity via the stress response pathway genes skn1, ire-1, and xbp-1. Cell.Rep. 17: 1227-1237.
45. Denzel MS, Storm NJ, Gutschmidt A, Baddi R, Hinze Y, Jarosch E, Sommer T,
Hoppe T, Antebi A. 2014. Hexosamine pathway metabolites enhance protein quality
control and prolong life. Cell 156: 1167-1178.
46. Lapierre LR, Gelino S, Melendez A, Hansen M. 2011. Autophagy and lipid
metabolism coordinately modulate life span in germline-less C. elegans. Curr.Biol. 21:
1507-1514.
47. Skovronsky DM, Lee VM, Trojanowski JQ. 2006. Neurodegenerative diseases: New
concepts of pathogenesis and their therapeutic implications. Annu.Rev.Pathol.Mech.Dis.
1: 151-170.
48. Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M. 2004.
Induction of neuronal death by ER stress in Alzheimer's disease. J.Chem.Neuroanat. 28:
67-78.
49. Hetz C, Saxena S. 2017. ER stress and the unfolded protein response in
neurodegeneration. Nat Rev Neurol. 13: 477-491.
50. Verkhratsky A. 2005. Physiology and pathophysiology of the calcium store in the
endoplasmic reticulum of neurons. Physiol.Rev. 85: 201-279.

31

51. Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, Hitomi J, Morihara T,
Yoneda T, Gomi F, Mori Y, Nakano Y, Takeda J, Tsuda T, Itoyama Y, Murayama O,
Takashima A, St George-Hyslop P, Takeda M, Tohyama M. 1999. Presenilin-1 mutations
downregulate the signalling pathway of the unfolded-protein response. Nat.Cell Biol. 1:
479-485.
52. Regitz C, Fitzenberger E, Mahn FL, Dussling LM, Wenzel U. 2016. Resveratrol
reduces amyloid-beta (aβ1-42)-induced paralysis through targeting proteostasis in an
Alzheimer model of Caenorhabditis elegans. Eur.J.Nutr. 55: 741-747.
53. Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas DE,
Fernandez-Funez P. 2011. The ER stress factor XBP1s prevents amyloid-beta
neurotoxicity. Hum.Mol.Genet. 20: 2144-2160.
54. Safra M, Ben-Hamo S, Kenyon C, Henis-Korenblit S. 2013. The ire-1 ER stressresponse pathway is required for normal secretory-protein metabolism in C. elegans.
J.Cell.Sci. 126: 4136-4146.
55. Lindholm D, Wootz H, Korhonen L. 2006. ER stress and neurodegenerative diseases.
Cell.Death.Differ. 13: 385-392.
56. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K,
Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD,
Labaer J, Rochet JC, Bonini NM, Lindquist S. 2006. Α-synuclein blocks ER-golgi traffic
and Rab1 rescues neuron loss in Parkinson's models. Science 313: 324-328.
57. Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S, Battistin L,
Spillantini M, Missale C, Spano P. 2011. Induction of the unfolded protein response by
α-synuclein in experimental models of parkinson's disease. J.Neurochem. 116: 588-605.
58. Mercado G, Valdes P, Hetz C. 2013. An ERcentric view of Parkinson's disease.
Trends Mol.Med. 19: 165-175.
59. Yuan Y, Cao P, Smith MA, Kramp K, Huang Y, Hisamoto N, Matsumoto K,
Hatzoglou M, Jin H, Feng Z. 2011. Dysregulated LRRK2 signaling in response to
endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans.
PLoS One 6: e22354.
60. Ross CA, Tabrizi SJ. 2011. Huntington's disease: From molecular pathogenesis to
clinical treatment. Lancet Neurol. 10: 83-98.
61. Duennwald ML, Lindquist S. 2008. Impaired ERAD and ER stress are early and
specific events in polyglutamine toxicity. Genes Dev. 22: 3308-3319.

32

62. Vidal R, Caballero B, Couve A, Hetz C. 2011. Converging pathways in the
occurrence of endoplasmic reticulum (ER) stress in Huntington's disease. Curr.Mol.Med.
11: 1-12.
63. Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM,
Morimoto R. 2000. Polyglutamine aggregates alter protein folding homeostasis in
Caenorhabditis elegans. Proc.Natl.Acad.Sci.U.S.A. 97: 5750-5755.
64. Angeli S, Barhydt T, Jacobs R, Killilea DW, Lithgow GJ, Andersen JK. 2014.
Manganese disturbs metal and protein homeostasis in Caenorhabditis elegans.
Metallomics 6: 1816-1823.
65. Cnop M, Foufelle F, Velloso LA. 2012. Endoplasmic reticulum stress, obesity and
diabetes. Trends Mol.Med. 18: 59-68.
66. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun
C, Glimcher LH, Hotamisligil GS. 2004. Endoplasmic reticulum stress links obesity,
insulin action, and type 2 diabetes. Science 306: 457-461.
67. Fu S, Yang L, Li P, Hofmann O, Dicker L, Hide W, Lin X, Watkins SM, Ivanov AR,
Hotamisligil GS. 2011. Aberrant lipid metabolism disrupts calcium homeostasis causing
liver endoplasmic reticulum stress in obesity. Nature 473: 528-531.
68. Hou NS, Gutschmidt A, Choi DY, Pather K, Shi X, Watts JL, Hoppe T, Taubert S.
2014. Activation of the endoplasmic reticulum unfolded protein response by lipid
disequilibrium without disturbed proteostasis in vivo. Proc.Natl.Acad.Sci.U.S.A. 111:
E2280.
69. Mayer CM, Belsham DD. 2010. Palmitate attenuates insulin signaling and induces
endoplasmic reticulum stress and apoptosis in hypothalamic neurons: Rescue of
resistance and apoptosis through adenosine 5' monophosphate-activated protein kinase
activation. Endocrinology 151: 576-585.
70. Li Y, Ge M, Ciani L, Kuriakose G, Westover EJ, Dura M, Covey DF, Freed JH,
Maxfield FR, Lytton J, Tabas I. 2004. Enrichment of endoplasmic reticulum with
cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in
parallel with increased order of membrane lipids: Implications for depletion of
endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages.
J.Biol.Chem. 279: 37030-37039.
71. Wang Y, Vera L, Fischer WH, Montminy M. 2009. The CREB coactivator CRTC2
links hepatic ER stress and fasting gluconeogenesis. Nature 460: 534-537.
72. Jones KT, Ashrafi K. 2009. Caenorhabditis elegans as an emerging model for
studying the basic biology of obesity. Dis.Model.Mech. 2: 224-229.

33

73. Rong X, Albert CJ, Hong C, Duerr MA, Chamberlain BT, Tarling EJ, Ito A, Gao J,
Wang B, Edwards PA, Jung ME, Ford DA, Tontonoz P. 2013. LXRs regulate ER stress
and inflammation through dynamic modulation of membrane phospholipid composition.
Cell.Metab. 18: 685-697.
74. Stiernagle T. 2006. Maintenance of C. elegans. In WormBook : The online review of
C.elegans biology. Chalfie M, ed. The C. elegans Research Community, New York, NY,
United States, p 1-11.
75. Shen P, Kershaw JC, Yue Y, Wang O, Kim KH, McClements DJ, Park Y. 2018.
Effects of conjugated linoleic acid (CLA) on fat accumulation, activity, and proteomics
analysis in Caenorhabditis elegans. Food Chem. 249: 193-201.
76. Ward A, Walker VJ, Feng Z, Xu XZ. 2009. Cocaine modulates locomotion behavior
in C. elegans. PLoS One 4: e5946.
77. Zeng R, Yu X, Tan X, Ye S, Ding Z. 2017. Deltamethrin affects the expression of
voltage-gated calcium channel alpha1 subunits and the locomotion, egg-laying, foraging
behavior of Caenorhabditis elegans. Pestic.Biochem.Physiol. 138: 84-90.
78. Toumi H, Boumaiza M, Millet M, Radetski CM, Felten V, Fouque C, Ferard JF. 2013.
Effects of deltamethrin (pyrethroid insecticide) on growth, reproduction, embryonic
development and sex differentiation in two strains of Daphnia magna (crustacea,
cladocera). Sci.Total Environ. 458-460: 47-53.
79. Morley JF, Brignull HR, Weyers JJ, Morimoto RI. 2002. The threshold for
polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and
influenced by aging in Caenorhabditis elegans. Proc.Natl.Acad.Sci.U.S.A. 99: 1041710422.
80. Nahabedian JF, Qadota H, Stirman JN, Lu H, Benian GM. 2012. Bending amplitude a new quantitative assay of C. elegans locomotion: Identification of phenotypes for
mutants in genes encoding muscle focal adhesion components. Methods 56: 95-102.
81. Laugeray A, Herzine A, Perche O, Richard O, Montecot-Dubourg C, Menuet A,
Mazaud-Guittot S, Lesne L, Jegou B, Mortaud S. 2017. In utero and lactational exposure
to low-doses of the pyrethroid insecticide cypermethrin leads to neurodevelopmental
defects in male mice-an ethological and transcriptomic study. PLoS One 12: e0184475.
82. Oliveira JM, Losano NF, Condessa SS, de Freitas, R M P, Cardoso SA, Freitas MB,
de Oliveira LL. 2018. Exposure to deltamethrin induces oxidative stress and decreases of
energy reserve in tissues of the neotropical fruit-eating bat Artibeus lituratus.
Ecotoxicol.Environ.Saf. 148: 684-692.

34

83. Richardson CE, Kinkel S, Kim DH. 2011. Physiological IRE-1-XBP-1 and PEK-1
signaling in Caenorhabditis elegans larval development and immunity. PLoS Genet. 7:
e1002391.
84. Kung TS, Richardson JR, Cooper KR, White LA. 2015. Developmental deltamethrin
exposure causes persistent changes in dopaminergic gene expression, neurochemistry,
and locomotor activity in Zebrafish. Toxicol.Sci. 146: 235-243.
85. Boulin T, Etchberger JF, Hobert O. 2006. Reporter gene fusions. In WormBook.
Chalfie M, ed. The C. elegans Research Community, New York, NY, United States.
86. Bracci L, Vukcevic M, Spagnoli G, Ducreux S, Zorzato F, Treves S. 2007. Ca2+
signaling through ryanodine receptor 1 enhances maturation and activation of human
dendritic cells. J.Cell.Sci. 120: 2232.

35

